How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy

被引:55
作者
Quarmby, V
Quan, C
Ling, V
Compton, P
Canova-Davis, E
机构
[1] Genentech Inc, Dept Bioanalyt Technol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Analyt Chem, San Francisco, CA 94080 USA
关键词
D O I
10.1210/jc.83.4.1211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a significant systematic difference between the normal range obtained from ethylenediamine tetraacetate plasma samples using the Genentech total insulin-like growth factor I (IGF-I) RIA and normal ranges for other total IGF-I RIAs. To determine whether the quality of the assay standard was the cause of this systematic difference, we analyzed commercially available preparations of recombinant human IGF-I (rhIGF-I) typical of those used as IGF-I immunoassay standards along with our own well characterized rhIGF-I assay standard. For the commercial standards, high performance liquid chromatography-derived purities were low, and some vendor-assigned protein concentrations were inconsistent with values from quantitative amino acid analysis. The Genentech rhIGF-I assay standard was highly pure and quantitatively correct. However, the poor quality of some commercial rhIGF-I preparations was not the primary reason for the systematic discrepancy between the Genentech total IGF-I RIA normal range and most other normal ranges. Most assays for total IGF-I are calibrated against the WHO International Reference Reagent (IRR) for IGF-I Immunoassays (87/ 518). The Genentech total IGF-I RIA is not calibrated against WHO IRR 87/518. The protein content assigned to WHO IRR 87/518 was a consensus value from a multicenter collaborative study. Physicochemical analyses showed that WHO IRR 87/518 is Met(-1)-IGF-I of low purity (44%), and that the assigned protein content is higher than the value determined by quantitative amino acid analysis. Thus, assays that are calibrated against WHO IRR 87/518 will report total IGF-I concentrations in excess of actual values. We believe that calibration against WHO IRR 87/518 is the cause of the systematic discrepancy between the Genentech IGF-I assay normal range and most other normal ranges, and that much of the plasma IGF-I concentration data in the literature are of questionable accuracy.
引用
收藏
页码:1211 / 1216
页数:6
相关论文
共 50 条
  • [41] The role of insulin-like growth factor-I (IGF-I) and IGF-I receptor (IGF-IR) in hyperoxic lung injury in developing lungs
    Chetty, A
    Reddy, VM
    Nielsen, HC
    PEDIATRIC RESEARCH, 2000, 47 (04) : 354A - 354A
  • [42] Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: Evidence for a second mechanism of IGF-I signaling
    Pandini, G
    Vigneri, R
    Costantino, A
    Frasca, F
    Ippolito, A
    Fujita-Yamaguchi, Y
    Siddle, K
    Goldfine, ID
    Belfiore, A
    CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1935 - 1944
  • [43] Human conditions of insulin-like growth factor-I (IGF-I) deficiency
    Juan E Puche
    Inma Castilla-Cortázar
    Journal of Translational Medicine, 10
  • [44] EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) IN MARMOSET OVARY
    RODWAY, MR
    BIOLOGY OF REPRODUCTION, 1994, 50 : 122 - 122
  • [45] Issues in liquid formulation development for insulin-like Growth Factor I (IGF-I).
    Shirley, BA
    Bajwa, KK
    Lone, TA
    Arellano, SL
    Hora, MS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U239 - U239
  • [46] EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) IN NEVI AND MELANOMAS
    FLEMING, MG
    HOWE, SF
    GRAF, LH
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1994, 16 (04) : 383 - 391
  • [47] TAMOXIFEN REDUCES SERUM INSULIN-LIKE GROWTH FACTOR-I (IGF-I)
    POLLAK, MN
    HUYNH, H
    LEFEBVRE, SP
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (01) : 91 - 100
  • [48] PITUITARY AND HYPOTHALAMIC INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND IGF-I RECEPTOR EXPRESSION IN FOOD-DEPRIVED RATS
    OLCHOVSKY, D
    SONG, JF
    GELATO, MC
    SHERWOOD, J
    SPATOLA, E
    BRUNO, JF
    BERELOWITZ, M
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1993, 93 (02) : 193 - 198
  • [49] DISTRIBUTION OF CIRCULATING INSULIN-LIKE GROWTH FACTOR-I (IGF-I) INTO TISSUES
    HODGKINSON, SC
    SPENCER, GSG
    BASS, JJ
    DAVIS, SR
    GLUCKMAN, PD
    ENDOCRINOLOGY, 1991, 129 (04) : 2085 - 2093
  • [50] Insulin-like growth factor-I (IGF-I) prevents steroid myopathy
    Kanda, F
    Takatani, K
    Matsushita, T
    Okuda, S
    Chihara, K
    NEUROLOGY, 1997, 48 (03) : 5074 - 5074